Aquestive Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
Location
30 Technology Drive, Warren, NJ

Insiders trading volume in the past year

Aquestive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Mark Schobel Chief Innovation/Tech Officer $5.91M Mar 15, 2024
Daniel Barber President and CEO $2.69M Mar 7, 2025
Lori Braender Chief Legal Officer $1.07M Mar 7, 2025
Douglas K. Bratton 10%+ Owner $1.03M Dec 2, 2024
A. Ernest Toth Jr Chief Financial Officer $899K Mar 7, 2025
Stephen Wargacki Chief Science Officer $873K Mar 7, 2025
Carl N. Kraus Chief Medical Officer $831K Mar 7, 2025
Peter E. Boyd SVP, Information Technology, Human Resources and Communications $804K Mar 7, 2025
Cassie Jung Chief Operating Officer $756K -$214 -0.03% Mar 7, 2025
John Cochran Director $597K Jun 20, 2024
Keith J. Kendall CEO and President, Director $516K Mar 10, 2022
Gregory B. Brown Director $451K Jun 20, 2024
Sherry Korczynski SVP Sales and Marketing $423K Mar 7, 2025
Ken W. Marshall SVP, Chief Commercial Officer $123K Aug 9, 2023
Santo J. Costa Director $104K Jun 20, 2024
James S. Scibetta Director $25.6K Jun 15, 2021
Abigail L. Jenkins Director $0 May 10, 2024
Kenneth Truitt Chief Medical Officer Sep 6, 2022
Nancy Lurker Director Jun 15, 2021
Julie Krop Director Jun 20, 2024
Theresa Wood SVP-HR and Org. Development Mar 10, 2022
Timothy E. Morris Director Jun 20, 2024
Marco Taglietti Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Aquestive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.